Press Release

Researchers find proliferating cells in normal and diseased corneal endothelium

Researchers find proliferating cells in normal and diseased corneal endothelium

September 14, 2016

Findings published in the American Journal of Pathology offer new directions for treatment of patients with Fuchs’ Endothelial Corneal Dystrophy (FECD)

Boston, Mass. —  Researchers from Massachusetts Eye and Ear have, for the first time, identified rapidly proliferating cells (known as “neural crest-derived progenitor cells”) in the corneal endothelium of specimens from normal corneas and from corneas with Fuchs’ Endothelial Corneal Dystrophy (FECD), a condition in which the cells responsible for keeping the cornea...

Read more about Researchers find proliferating cells in normal and diseased corneal endothelium
Luk Vandenberghe

Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement with Massachusetts Eye and Ear

September 12, 2016
  • The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented technology and services to commercialize next generation gene therapies.
  • The Anc-AAV vector platform has the potential to overcome pre-existing immunity in order to treat more patients compared with other viral vectors currently in development.
  • Anc80, the lead novel Anc-AAV available for sublicensing, is a potent gene therapy vector capable of superior gene expression levels in...
Read more about Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement with Massachusetts Eye and Ear
Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives Physician-Scientist Award from Research to Prevent Blindness

Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives Physician-Scientist Award from Research to Prevent Blindness

July 15, 2016

BOSTON – (July 15, 2016) – Jennifer K. Sun, MD, MPH, Investigator in the Section on Vascular Biology at Joslin Diabetes Center, an Ophthalmologist in Beetham Eye Institute (BEI) at Joslin Diabetes Center, and Associate Professor at Harvard Medical School, has been granted an Physician-Scientist Award by Research to Prevent Blindness (RPB). Up to $300,000 will be...

Read more about Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives Physician-Scientist Award from Research to Prevent Blindness

Priya Gupta Awarded RPB Medical Student Eye Research Fellowship

June 23, 2016

Boston, Mass. — The Department of Ophthalmology at Harvard Medical School has been granted a $30,000 Research to Prevent Blindness (RPB) Medical Student Research Fellowship in support of Priya Gupta. This award will allow Gupta to spend one year studying inherited retinal degenerations (IRDs), a devastating cause of blindness throughout the world affecting approximately 1.5 million patients of all ages. She will work under the mentorship of Eric Pierce, MD, PhD...

Read more about Priya Gupta Awarded RPB Medical Student Eye Research Fellowship
Lotfi Merabet

Lotfi B. Merabet, PhD, OD, Receives Low Vision Research Award

June 23, 2016

Boston, Mass. —  Lotfi B. Merabet, PhD, OD, MPH, an optometrist and vision researcher at Massachusetts Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School, is the 2016 recipient of the Low Vision Research Award from Research to Prevent Blindness (RPB) and the Lions Clubs International Foundation (LCIF). Dr. Merabet will receive $300,000 over three years for...

Read more about Lotfi B. Merabet, PhD, OD, Receives Low Vision Research Award
Luk Vandenberghe

Selecta Biosciences obtains exclusive license to proprietary gene therapy vector from Massachusetts Eye and Ear

May 19, 2016

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to avoid several immunogenicity challenges that limit the development of gene therapies today 

Watertown, Mass. — Selecta Biosciences, Inc., a clinical-stage biopharmaceutical...

Read more about Selecta Biosciences obtains exclusive license to proprietary gene therapy vector from Massachusetts Eye and Ear
gang luo google glass

Researchers develop magnifying smartphone screen application using Google Glass for visually impaired

April 22, 2016

Mass. Eye and Ear researchers have designed technology to improve upon the built-in zoom feature of smartphones, which many low-vision users find difficult to use due to a loss of context.


BOSTON – Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear/Harvard Medical School have developed a smartphone application that projects a magnified smartphone screen to Google Glass, which users can navigate using head movements...

Read more about Researchers develop magnifying smartphone screen application using Google Glass for visually impaired
Researchers Find Immunosuppressive Medication An Effective Treatment For Ocular Graft-Versus-Host-Disease

Researchers Find Immunosuppressive Medication An Effective Treatment For Ocular Graft-Versus-Host-Disease

April 13, 2016

A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and showed fewer hypertensive side effects in treating...

Read more about Researchers Find Immunosuppressive Medication An Effective Treatment For Ocular Graft-Versus-Host-Disease